We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Newer Cardiac Imaging Technology Accurately Identifies Coronary Artery Stenosis

By HospiMedica International staff writers
Posted on 22 Sep 2008
The first multicenter study of the accuracy of some of the latest cardiac imaging systems revealed that they were 99% effective in ruling out obstructive coronary artery stenosis (narrowing of these arteries) as compared with the more costly and invasive coronary angiography systems conventionally used by clinicians.

Matthew J. More...
Budoff, M.D., a principal investigator at the Los Angeles Biomedical Research Institute at Harbor-the University of California, Los Angeles (UCLA) Medical Center (LA BioMed), is the lead investigator of the study conducted at 16 different sites with 230 research volunteers with chest pain but no known coronary artery disease.

"The research found this noninvasive method of cardiac imaging will effectively detect stenosis--a constriction or narrowing--of the coronary arteries which can lead to heart attacks and may require surgery to repair,” Dr. Budoff said. "This is good news for patients who, in the past, might have been forced to undergo a more expensive and invasive procedure to determine if they suffered from blockages in the arteries leading to their hearts.”

In the study, each of the research volunteers was evaluated using some of the newer cardiac computed tomography (CT) technology--electrocardiographically gated 64-multidetector row coronary CT angiography (CCTA). Each volunteer also underwent the more expensive and invasive coronary angiography, which is frequently called the "gold standard” for evaluating coronary artery stenosis.

The researchers discovered CCTA provided high diagnostic accuracy for detection of obstructive coronary stenosis at the thresholds of a 50% narrowing and at 70% stenosis. It also found CCTA was accurate 99% of the time in ruling out coronary artery stenosis.

The study was sponsored by GE Healthcare (Chalfont St. Giles, UK), which manufactures the cardiac CT imaging devices used in the study.

Related Links:
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
GE Healthcare

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Imaging Table
Stille imagiQ2
OR Table Accessory
Angular Accessory Rail
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.